A former drug addict said that ketamine should be a Class A drug as data revealed the number of people being treated in ...

The constant evolution of new COVID-19 variants makes it critical for clinicians to have multiple therapies in their arsenal for treating drug-resistant infections. Researchers have now discovered ...

Move over fentanyl! There's a new boogeyman in town. At least that's what you might be hearing from the news. And if you haven't already heard the word "nitazenes" then you can expect to soon.

A first-in-class drug engineered to selectively inhibit the signaling pathway of the cannabinoid receptor CB1 has shown promise as a safe and effective treatment for cannabis use disorder (CUD). Tests ...